BIO-FD&CLtd Past Earnings Performance
Past criteria checks 2/6
BIO-FD&CLtd has been growing earnings at an average annual rate of 28.8%, while the Biotechs industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 1.7% per year. BIO-FD&CLtd's return on equity is 9.5%, and it has net margins of 35.8%.
Key information
28.8%
Earnings growth rate
33.1%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | -1.7% |
| Return on equity | 9.5% |
| Net Margin | 35.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How BIO-FD&CLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15,592 | 5,585 | 4,323 | 1,429 |
| 30 Sep 23 | 14,947 | 4,725 | 4,088 | 1,449 |
| 30 Jun 23 | 13,988 | 4,337 | 3,746 | 1,569 |
| 31 Mar 23 | 14,832 | 5,120 | 4,088 | 1,467 |
| 31 Dec 22 | 15,855 | 4,335 | 4,538 | 1,449 |
| 30 Sep 22 | 16,368 | 3,874 | 4,331 | 1,256 |
| 30 Jun 22 | 15,881 | 3,691 | 4,400 | 990 |
| 31 Mar 22 | 14,092 | 2,517 | 3,534 | 1,285 |
| 31 Dec 21 | 11,972 | 2,908 | 2,959 | 816 |
Quality Earnings: A251120 has high quality earnings.
Growing Profit Margin: A251120's current net profit margins (35.8%) are higher than last year (27.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A251120's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A251120's past year earnings growth to its 5-year average.
Earnings vs Industry: A251120 earnings growth over the past year (28.8%) did not outperform the Biotechs industry 28.8%.
Return on Equity
High ROE: A251120's Return on Equity (9.5%) is considered low.